Histologic variation in high grade oral epithelial dysplasia when associated with high-risk human papillomavirus

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 May;123(5):566-585. doi: 10.1016/j.oooo.2017.01.008. Epub 2017 Jan 24.

Abstract

Objectives: Reported cytologic alterations associated with high-risk human papillomavirus (HR-HPV) in oral epithelial dysplasia (HPV-OED) need further characterization.

Study design: Archival cases of high-grade oral epithelial dysplasia (hgOED) (N = 38) were assigned a cytologic score (CS) based on the average number of mitotic, karyorrhectic, and apoptotic cells per high-power field. Three groups were then generated on the basis of increasing CS: Focal (group 1, N = 14), Intermediate (group 2, N = 12), and Diffuse (group 3, N = 12). Polymerase chain reaction-based HPV genotyping and p16 immunohistochemistry were performed.

Results: HR-HPV was found significantly more in group 3 (83.3%) compared with groups 1 and 2 (group 1&2; 42.9% and 41.7%, respectively; P = .047). HPV16 predominated in HR-HPV-positive cases (90.5%). By location, the tongue or the floor of mouth was associated with all groups (P = .04). Increasing CS was associated with a slightly younger age (P = .04) and increased expression of p16 (P = .005). CS and p16 expression were not sensitive but were highly specific predictors for HR-HPV presence. Based on limited follow-up information, HPV-OED does not differ in clinical aggressiveness compared with conventional OED.

Conclusions: Increased CS in hgOED is strongly associated with HR-HPV (mostly HPV16) and p16 expression. CS and p16 expression are specific predictors of HR-HPV presence. Further molecular study and long-term follow-up of HPV-OED are needed.

MeSH terms

  • Adult
  • Apoptosis
  • Carcinoma in Situ / virology
  • Cell Differentiation
  • Cell Proliferation
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mouth Diseases / virology*
  • Mouth Neoplasms / virology*
  • Papillomavirus Infections / pathology*
  • Polymerase Chain Reaction
  • Precancerous Conditions / virology*
  • Risk Factors

Substances

  • Cyclin-Dependent Kinase Inhibitor p16